JS Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
O'Reilly Automotive
ORLY
|
+$40.3M |
| 2 |
Amazon
AMZN
|
+$32.9M |
| 3 |
Fidelity National Information Services
FIS
|
+$32.3M |
| 4 |
Microsoft
MSFT
|
+$28M |
| 5 |
Booking.com
BKNG
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$20.4M |
| 2 |
DAY
Dayforce
DAY
|
+$16.3M |
| 3 |
VICI Properties
VICI
|
+$16M |
| 4 |
FSCT
ForeScout Technologies, Inc. Common Stock
FSCT
|
+$15.6M |
| 5 |
Equifax
EFX
|
+$15.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 45.66% |
| 2 | Technology | 22.86% |
| 3 | Healthcare | 12.16% |
| 4 | Communication Services | 12.05% |
| 5 | Real Estate | 2.28% |
Similar funds
JS Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, JS Capital Management held 222 positions worth $795M, down 8.4% from $868M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
JS Capital Management deployed $67.5M of net new capital in Q1 2020, opening 103 new positions and adding to 11 existing holdings. Its largest new stake was O'Reilly Automotive: 1,578,000 shares worth $31.7M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 46% of assets, up from 41% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was 10x Genomics, an estimated $20.4M trimmed.
- JS Capital Management's largest Q1 2020 buy was O'Reilly Automotive: 1,578,000 shares worth $31.7M.
- JS Capital Management added most to Amazon in Q1 2020, an estimated $32.9M increase.
- JS Capital Management's biggest Q1 2020 reduction was 10x Genomics, cutting an estimated $20.4M.
- JS Capital Management fully exited Dayforce in Q1 2020, selling an estimated $16.3M.
- JS Capital Management's ten largest holdings make up 77% of its $795M portfolio in Q1 2020.
- JS Capital Management opened 103 new positions and closed 97 in Q1 2020.
- JS Capital Management's portfolio value fell 8.4% quarter-over-quarter to $795M.
Based on JS Capital Management's 13F filing for Q1 2020, filed 15 May 2020.